In Otsuka Long-Evans Tokushima fatty (OLETF) rats, a T2DM animal model, dilazep administration slowed the increase in urinary protein excretions and reduced the activity of N-acetyl-beta-D-glucosaminidase (NAG) [176]. The gene discussed is OGA; the disease is type 2 diabetes mellitus.